GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision
6th September 2024 Uncategorised 0 GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision
fkansteiner
Fri, 09/06/2024 – 09:29
More: GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision
Source: fierce
